185 related articles for article (PubMed ID: 12436917)
21. Tumour-selective drug delivery via folate receptor-targeted liposomes.
Pan X; Lee RJ
Expert Opin Drug Deliv; 2004 Nov; 1(1):7-17. PubMed ID: 16296717
[TBL] [Abstract][Full Text] [Related]
22. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro.
Lee RJ; Low PS
Biochim Biophys Acta; 1995 Feb; 1233(2):134-44. PubMed ID: 7865538
[TBL] [Abstract][Full Text] [Related]
23. Folate-linked lipid-based nanoparticle for targeted gene delivery.
Hattori Y; Maitani Y
Curr Drug Deliv; 2005 Jul; 2(3):243-52. PubMed ID: 16305426
[TBL] [Abstract][Full Text] [Related]
24. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
Goren D; Horowitz AT; Tzemach D; Tarshish M; Zalipsky S; Gabizon A
Clin Cancer Res; 2000 May; 6(5):1949-57. PubMed ID: 10815920
[TBL] [Abstract][Full Text] [Related]
25. Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents.
Glickson JD; Lund-Katz S; Zhou R; Choi H; Chen IW; Li H; Corbin I; Popov AV; Cao W; Song L; Qi C; Marotta D; Nelson DS; Chen J; Chance B; Zheng G
Mol Imaging; 2008; 7(2):101-10. PubMed ID: 18706292
[TBL] [Abstract][Full Text] [Related]
26. Folate receptor-mediated liposomal delivery of a lipophilic boron agent to tumor cells in vitro for neutron capture therapy.
Sudimack JJ; Adams D; Rotaru J; Shukla S; Yan J; Sekido M; Barth RF; Tjarks W; Lee RJ
Pharm Res; 2002 Oct; 19(10):1502-8. PubMed ID: 12425468
[TBL] [Abstract][Full Text] [Related]
27. Construction of anti-EGFR immunoliposomes via folate-folate binding protein affinity.
Pan X; Lee RJ
Int J Pharm; 2007 May; 336(2):276-83. PubMed ID: 17212981
[TBL] [Abstract][Full Text] [Related]
28. Folate-mediated targeting of antineoplastic drugs, imaging agents, and nucleic acids to cancer cells.
Wang S; Low PS
J Control Release; 1998 Apr; 53(1-3):39-48. PubMed ID: 9741912
[TBL] [Abstract][Full Text] [Related]
29. A novel pH-sensitive liposome formulation containing oleyl alcohol.
Sudimack JJ; Guo W; Tjarks W; Lee RJ
Biochim Biophys Acta; 2002 Aug; 1564(1):31-7. PubMed ID: 12100993
[TBL] [Abstract][Full Text] [Related]
30. Folate receptor targeted bimodal liposomes for tumor magnetic resonance imaging.
Kamaly N; Kalber T; Thanou M; Bell JD; Miller AD
Bioconjug Chem; 2009 Apr; 20(4):648-55. PubMed ID: 19368341
[TBL] [Abstract][Full Text] [Related]
31. Optimization of folate-conjugated liposomal vectors for folate receptor-mediated gene therapy.
Reddy JA; Dean D; Kennedy MD; Low PS
J Pharm Sci; 1999 Nov; 88(11):1112-8. PubMed ID: 10564057
[TBL] [Abstract][Full Text] [Related]
32. Targeted drug delivery via the folate receptor.
Sudimack J; Lee RJ
Adv Drug Deliv Rev; 2000 Mar; 41(2):147-62. PubMed ID: 10699311
[TBL] [Abstract][Full Text] [Related]
33. Addition of TPGS to folate-conjugated polymer micelles for selective tumor targeting.
Zhao H; Yung LY
J Biomed Mater Res A; 2009 Nov; 91(2):505-18. PubMed ID: 18985763
[TBL] [Abstract][Full Text] [Related]
34. Folate-mediated delivery of macromolecular anticancer therapeutic agents.
Lu Y; Low PS
Adv Drug Deliv Rev; 2002 Sep; 54(5):675-93. PubMed ID: 12204598
[TBL] [Abstract][Full Text] [Related]
35. Folate-targeted chemotherapy.
Leamon CP; Reddy JA
Adv Drug Deliv Rev; 2004 Apr; 56(8):1127-41. PubMed ID: 15094211
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of New Folate Receptor-mediated Mitoxantrone Targeting Liposomes
Wen T; Gao Y; Zheng Y; Shan B; Song C; An Y; Cui J
Curr Pharm Biotechnol; 2024; 25(4):510-519. PubMed ID: 37957921
[TBL] [Abstract][Full Text] [Related]
37. Folate receptor-mediated cancer cell specific gene delivery using folic acid-conjugated oligochitosans.
Lee D; Lockey R; Mohapatra S
J Nanosci Nanotechnol; 2006; 6(9-10):2860-6. PubMed ID: 17048492
[TBL] [Abstract][Full Text] [Related]
38. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
[TBL] [Abstract][Full Text] [Related]
39. [Tumor cell targetability of folate receptor-mediated mitoxantrone albumin nanoparticles].
Zhang LK; Hou SX; Mao SJ; Wei DP; Song XR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):77-9. PubMed ID: 16468648
[TBL] [Abstract][Full Text] [Related]
40. Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates.
Gabizon A; Shmeeda H; Horowitz AT; Zalipsky S
Adv Drug Deliv Rev; 2004 Apr; 56(8):1177-92. PubMed ID: 15094214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
